éå»1ã¶æéã«Aurinia Pharmaceuticals Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã7åã«åºã¥ãããŒã¿ã
仿ãAUPHã¯3ä»¶ã®ãè²·ããã3ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããAUPHã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯17.857ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS 0.288ã«ç¶ããAUPHã®FY2026Q3ã®EPSã¯0.220ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 0.29 ã§ããããAurinia Pharmaceuticals IncAUPH ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 0.26 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD 0.22 ãšäºæ³ãããŸãã